![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Browning RM, Trentino K, Nathan EA, Hashemi N, & The Western Australian Patient Blood Management, P. 2012. Preoperative anaemia is common in patients undergoing major gynaecological surgery and is associated with a fivefold increased risk of transfusion. The Australian and New Zealand Journal of Obstetrics and Gynaecology 52:455–459.
- Bulun SE, Moravek MB, Yin P, Ono M, Coon JST, Dyson MT, et al. 2015. Uterine leiomyoma stem cells: linking progesterone to growth. Seminars in Reproductive Medicine 33:357–365.
- Chabbert-Buffet N, Pintiaux-Kairis A, Bouchard P. 2007. Effects of the progesterone receptor modulator VA2914 in a continuous low dose on the hypothalamic-pituitary-ovarian axis and endometrium in normal women: a prospective, randomized, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism 92:3582–3589.
- Donnez J, Dolmans MM. 2016. Uterine fibroid management: from the present to the future. Human Reproduction Update 22:665–686.
- Donnez J, Donnez O, Matule D, Ahrendt HJ, Hudecek R, Zatik J, et al. 2016. Long-term medical management of uterine fibroids with ulipristal acetate. Fertility and Sterility 105:165–173.e4.
- Donnez J, Hudecek R, Donnez O, Matule D, Arhendt HJ, Zatik J, et al. 2015. Efficacy and safety of repeated use of ulipristal acetate in uterine fibroids. Fertility and Sterility 103:519–527.e3.
- Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, et al. 2012. Ulipristal acetate versus placebo for fibroid treatment before surgery. New England Journal of Medicine 366:409–420.
- Donnez J, Tomaszewski J, Vázquez F, Bouchard P, Lemieszczuk B, Baró F, et al. 2012. Ulipristal acetate versus leuprolide acetate for uterine fibroids. The New England Journal of Medicine 366:421–432.
- Donnez J, Vazquez F, Tomaszewski J, Nouri K, Bouchard P, Fauser BC, et al. 2014. Long-term treatment of uterine fibroids with ulipristal acetate. Fertility and Sterility 101:1565–1573. e1–18.
- Evans P, Brunsell S. 2007. Uterine fibroid tumors: diagnosis and treatment. American Family Physician 75:1503–1508.
- Flake GP, Moore AB, Sutton D, Kissling GE, Horton J, Wicker B, et al. 2013. The natural history of uterine leiomyomas: light and electron microscopic studies of fibroid phases, interstitial ischemia, inanosis, and reclamation. Obstetrics and Gynecology International 2013:20.
- Gupta S, Jose J, Manyonda I. 2008. Clinical presentation of fibroids. Best Practice & Research. Clinical Obstetrics and Gynaecology 22:615–626.
- Lethaby A, Vollenhoven B, Sowter MC. 2001. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database of Systematic Reviews (2):CD000547.
- Levens ED, Potlog-Nahari C, Armstrong AY, Wesley R, Premkumar A, Blithe DL, et al. 2008. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstetrics and Gynecology 111:1129–1136.
- Nieman LK, Blocker W, Nansel T, Mahoney S, Reynolds J, Blithe D, et al. 2011. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study. Fertility and Sterility 95:767–772.e1–2.
- Programme ERP. 2010. Delivering enhanced recovery—helping patients to get better sooner after surgery. Available from: http://www.dh.gov.uk/publications
- Trefoux Bourdet A, Luton D, Koskas M. 2015. Clinical utility of ulipristal acetate for the treatment of uterine fibroids: current evidence. International Journal of Women’s Health 7:321–330.
- Van Voorhis B. 2009. A 41-year-old woman with menorrhagia, anemia, and fibroids: review of treatment of uterine fibroids. JAMA 301:82–93.
- Wallach EE, Vlahos NF. 2004. Uterine myomas: an overview of development, clinical features, and management. Obstetrics and Gynecology 104:393–406.
- Yoshida S, Ohara N, Xu Q, Chen W, Wang J, Nakabayashi K, et al. 2010. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. Seminars in Reproductive Medicine 28:260–273.
- Zapata LB, Whiteman MK, Tepper NK, Jamieson DJ, Marchbanks PA, Curtis KM. 2010. Intrauterine device use among women with uterine fibroids: a systematic review. Contraception 82:41–55.